Retatrutide has emerged as a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By activating these https://janegptx142650.blogofchange.com/36929385/retatrutide-a-promising-new-treatment-for-obesity